NovoCure Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:038 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
02 Nov 24	Sell€677	Mukund Paravasthu	Individual	44	€15.38
01 Nov 24	Sell€8,785	Frank Leonard	Individual	598	€14.69
01 Nov 24	Sell€2,342	Mukund Paravasthu	Individual	160	€14.64
31 Oct 24	Sell€11,781	Michael Puri	Individual	810	€14.54
02 Aug 24	Sell€12,689	Ashley Cordova	Individual	688	€18.44
04 Jun 24	Sell€21,162	Timothy Scannell	Individual	964	€21.95
04 Jun 24	Sell€21,160	Kinyip Leung	Individual	964	€21.95
04 Jun 24	Sell€21,167	William Vernon	Individual	964	€21.96
04 Mar 24	Sell€37,157	Frank Leonard	Individual	2,519	€14.76
04 Mar 24	Sell€49,030	Wilhelmus C. Groenhuysen	Individual	3,324	€14.76
28 Feb 24	Sell€34,314	Wilhelmus C. Groenhuysen	Individual	2,303	€14.90
28 Feb 24	Sell€30,962	Frank Leonard	Individual	2,078	€14.90

Insider Trading Volume

Insider Buying: 038 insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of 038?
Owner Type	Number of Shares	Ownership Percentage
General Public	5,077,116	4.69%
Individual Insiders	9,689,098	8.95%
Institutions	93,435,220	86.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 81.79% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
15%	FMR LLC	16,231,582	€480.4m	0.56%	0.03%
11.8%	BlackRock, Inc.	12,779,190	€378.2m	5.33%	0.01%
11.3%	Capital Research and Management Company	12,265,184	€363.0m	-12.6%	0.02%
11%	The Vanguard Group, Inc.	11,844,608	€350.5m	6.45%	0.01%
7.52%	Hansjoerg Wyss	8,141,397	€241.0m	0%	no data
4.74%	T. Rowe Price Group, Inc.	5,128,329	€151.8m	32.6%	0.01%
2.8%	Nordwand Advisors, LLC	3,029,824	€89.7m	100%	22.98%
2.52%	State Street Global Advisors, Inc.	2,729,988	€80.8m	-9.17%	no data
2.22%	Geode Capital Management, LLC	2,405,257	€71.2m	1.26%	0.01%
1.53%	Baillie Gifford & Co.	1,659,314	€49.1m	-1.67%	0.02%
0.98%	UBS Asset Management AG	1,062,969	€31.5m	-13.9%	no data
0.95%	Voloridge Investment Management, LLC	1,028,425	€30.4m	-6.9%	0.12%
0.92%	Federated Hermes, Inc.	997,444	€29.5m	34.3%	0.08%
0.89%	Two Sigma Advisers, LP	963,900	€28.5m	-26.9%	0.07%
0.85%	Northern Trust Global Investments	923,509	€27.3m	84.2%	no data
0.81%	Frontier Capital Management Co LLC	871,420	€25.8m	-15.3%	0.23%
0.78%	Balyasny Asset Management L.P.	839,174	€24.8m	41%	0.07%
0.76%	Charles Schwab Investment Management, Inc.	824,443	€24.4m	2.02%	no data
0.72%	Marshall Wace LLP	779,670	€23.1m	56.7%	0.03%
0.69%	Renaissance Technologies LLC	744,154	€22.0m	-2.11%	0.03%
0.68%	Two Sigma Investments, LP	739,954	€21.9m	-40.5%	0.05%
0.61%	Goldman Sachs Group, Investment Banking and Securities Investments	655,093	€19.4m	935%	0.01%
0.6%	D. E. Shaw & Co., L.P.	650,314	€19.2m	-7%	0.03%
0.56%	Coatue Management, L.L.C.	608,672	€18.0m	0%	0.06%
0.55%	Palo Alto Investors LP	593,540	€17.6m	5.63%	2.57%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/23 12:24
End of Day Share Price	2024/12/23 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

NovoCure Limited is covered by 15 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Difei Yang	Aegis Capital Corporation
Gregory Gilbert	Deutsche Bank
Vijay Kumar	Evercore ISI